Skip to main content
Nature Communications logoLink to Nature Communications
. 2021 Jun 21;12:3984. doi: 10.1038/s41467-021-24300-8

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

Xuping Xie 1,✉,#, Antonio E Muruato 1,2,#, Xianwen Zhang 1, Kumari G Lokugamage 2, Camila R Fontes-Garfias 1, Jing Zou 1, Jianying Liu 2, Ping Ren 3, Mini Balakrishnan 4, Tomas Cihlar 4, Chien-Te K Tseng 2, Shinji Makino 2, Vineet D Menachery 2,3,5, John P Bilello 4,, Pei-Yong Shi 1,5,6,7,
PMCID: PMC8216087  PMID: 34155200

Correction to: Nature Communications 10.1038/s41467-020-19055-7, published online 15 October 2020

The original version of this Article contained an error in the Acknowledgements, which incorrectly listed the NIH grant ‘AI142759’. This has been corrected in both the PDF and HTML versions of the Article.

Footnotes

The original article can be found online at 10.1038/s41467-020-19055-7.

These authors contributed equally: Xuping Xie, Antonio E. Muruato.

Contributor Information

Xuping Xie, Email: xuxie@UTMB.edu.

John P. Bilello, Email: john.bilello@gilead.com

Pei-Yong Shi, Email: peshi@UTMB.edu.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES